Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility (Composite) Nbr of analysts
19
27
23
22
27
20
19
20
24
28
23
26
23
28
22
14
16
16
17
Average 22
Weighted average by Cap. 23
Other Pharmaceuticals